Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Parry

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Investigative Ophthalmology & Visual Science|March 20, 2012
Recessive mutations in TSPAN12 cause retinal dysplasia and severe familial exudative vitreoretinopathy (FEVR)James A Poulter, Alice E Davidson, Manir Ali, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
Modulating the interaction between CDK2 and cyclin A with a quinoline-based inhibitorYongqi Deng, Gerald W Shipps, Lianyun Zhao, et al.
American Journal of Human Genetics|February 10, 2009
Mutations in CNNM4 cause Jalili syndrome, consisting of autosomal-recessive cone-rod dystrophy and amelogenesis imperfectaDavid A Parry, Alan J Mighell, Walid El-Sayed, et al.
American Journal of Human Genetics|October 4, 2016
Mutations in the pH-Sensing G-protein-Coupled Receptor GPR68 Cause Amelogenesis ImperfectaDavid A Parry, Claire E L Smith, Walid El-Sayed, et al.
Nature Genetics|November 28, 2018
Gain-of-function DNMT3A mutations cause microcephalic dwarfism and hypermethylation of Polycomb-regulated regionsPatricia Heyn, Clare V Logan, Adeline Fluteau, et al.
American Journal of Human Genetics|April 14, 2009
Null mutations in LTBP2 cause primary congenital glaucomaManir Ali, Martin McKibbin, Adam Booth, et al.
Nature Genetics|March 12, 2014
Mutations in TJP2 cause progressive cholestatic liver diseaseMelissa Sambrotta, Sandra Strautnieks, Efterpi Papouli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2012
Phase I and pharmacologic trial of cytosine arabinoside with the selective checkpoint 1 inhibitor Sch 900776 in refractory acute leukemiasJudith E Karp, Brian M Thomas, Jacqueline M Greer, et al.
Human Molecular Genetics|November 10, 2011
Next generation sequencing identifies mutations in Atonal homolog 7 (ATOH7) in families with global eye developmental defectsKamron Khan, Clare V Logan, Martin McKibbin, et al.
American Journal of Human Genetics|August 21, 2012
Mutations in C4orf26, encoding a peptide with in vitro hydroxyapatite crystal nucleation and growth activity, cause amelogenesis imperfectaDavid A Parry, Steven J Brookes, Clare V Logan, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Investigative Ophthalmology & Visual Science|March 20, 2012
Recessive mutations in TSPAN12 cause retinal dysplasia and severe familial exudative vitreoretinopathy (FEVR)James A Poulter, Alice E Davidson, Manir Ali, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
Modulating the interaction between CDK2 and cyclin A with a quinoline-based inhibitorYongqi Deng, Gerald W Shipps, Lianyun Zhao, et al.
American Journal of Human Genetics|February 10, 2009
Mutations in CNNM4 cause Jalili syndrome, consisting of autosomal-recessive cone-rod dystrophy and amelogenesis imperfectaDavid A Parry, Alan J Mighell, Walid El-Sayed, et al.
American Journal of Human Genetics|October 4, 2016
Mutations in the pH-Sensing G-protein-Coupled Receptor GPR68 Cause Amelogenesis ImperfectaDavid A Parry, Claire E L Smith, Walid El-Sayed, et al.
Nature Genetics|November 28, 2018
Gain-of-function DNMT3A mutations cause microcephalic dwarfism and hypermethylation of Polycomb-regulated regionsPatricia Heyn, Clare V Logan, Adeline Fluteau, et al.
American Journal of Human Genetics|April 14, 2009
Null mutations in LTBP2 cause primary congenital glaucomaManir Ali, Martin McKibbin, Adam Booth, et al.
Nature Genetics|March 12, 2014
Mutations in TJP2 cause progressive cholestatic liver diseaseMelissa Sambrotta, Sandra Strautnieks, Efterpi Papouli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2012
Phase I and pharmacologic trial of cytosine arabinoside with the selective checkpoint 1 inhibitor Sch 900776 in refractory acute leukemiasJudith E Karp, Brian M Thomas, Jacqueline M Greer, et al.
Human Molecular Genetics|November 10, 2011
Next generation sequencing identifies mutations in Atonal homolog 7 (ATOH7) in families with global eye developmental defectsKamron Khan, Clare V Logan, Martin McKibbin, et al.
American Journal of Human Genetics|August 21, 2012
Mutations in C4orf26, encoding a peptide with in vitro hydroxyapatite crystal nucleation and growth activity, cause amelogenesis imperfectaDavid A Parry, Steven J Brookes, Clare V Logan, et al.
Pageof 7